ESMO 2019 | Phase III trial: chemotherapy plus local-regional radiotherapy in pmNPCC

Ming-Yuan Chen

Ming-Yuan Chen, MD, PhD, Sun Yat-Sen University Cancer Center, Guangzhou, China, outlines the key findings from the Phase III trial regarding chemotherapy plus local-regional radiotherapy versus chemotherapy alone in primary metastatic nasopharyngeal carcinoma (NPC). This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video